Breaking
Friday, June 19, 2026

Drug Approvals

🇺🇸 FDA Page 6

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 61–72 of 665 articles

High impact AnalysisJun 6, 2026

Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN

FDA · IgAN · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

The FDA Amendments Act And Drug Safety: Twenty Years Later

FDA · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 6, 2026

FDA Issues June 2026 Guidance: Gene Therapy, Payor Comms, and CMC Flexibilities

FDA · 4 min

Dr. Sarah Mitchell
High impact NewsJun 6, 2026

Friday Five: ASCO Takeaways, ADA Focus, China Deals & More – Clinical Trials

4 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

May 2026 FDA Oncology Actions: 8 Approvals Reshape the Landscape

FDA · oncology · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

FDA clears U.S. trial of MAIA lung cancer drug for third-line patients

FDA · lung cancer · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

Pharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?

FDA · non-small cell lung cancer · 5 min

Dr. Sarah Mitchell
High impact NewsJun 6, 2026

Abivax colitis drug hits goal, but cancer cases rattle investors

colitis · 5 min

Dr. Sarah Mitchell
High impact NewsJun 6, 2026

Supreme Court sides with generic drug maker in icosapent ethyl patent case

U.S. Supreme Court · severe hypertriglyceridemia · 6 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

Rx Rundown: Pfizer, Hikma Pharmaceuticals, NewLimit — Drug Approvals & Catalyst Tracker

5 min

Dr. Sarah Mitchell
Critical impact NewsJun 5, 2026

MIRA Pharma Consolidates Global Rights to MIRA-55 and SKNY-1

5 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

4 Biotech Stocks Investors Should Watch in 2026: Market Analysis

4 min

Dr. Sarah Mitchell